S'abonner

Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma - 05/03/15

Doi : 10.1016/j.jaci.2014.10.020 
Euan R. Tovey, PhD a, , Sacha Stelzer-Braid, PhD b, c, Brett G. Toelle, PhD a, d, Brian G. Oliver, PhD a, e, Helen K. Reddel, MBBS, PhD a, Christiana M. Willenborg, BSc (Hons) b, Yvonne Belessis, MBBS, PhD f, g, Frances L. Garden, MBiostat a, h, i, Adam Jaffe, MBBS, MD f, g, Roxanne Strachan, BN g, Darryl Eyles, PhD j, k, William D. Rawlinson, PhD b, g, Guy B. Marks, PhD a, i
a Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia 
b Virology Research Laboratory, SEALS, Prince of Wales Hospital, Sydney, Australia 
c School of Medical Sciences, University of New South Wales, Sydney, Australia 
d Sydney Local Health District, Sydney, Australia 
e University of Technology Sydney, Sydney, Australia 
f School of Women's and Children's Health, University of New South Wales, Sydney, Australia 
g Sydney Children's Hospital, Sydney, Australia 
h Ingham Institute of Applied Medical Research, New South Wales, Sydney, Australia 
i South Western Sydney Clinical School, University of New South Wales, Sydney, Australia 
j Queensland Brain Institute, University of Queensland, Brisbane, Australia 
k Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Brisbane, Australia 

Corresponding author: Euan R. Tovey, PhD, Woolcock Institute of Medical Research, PO Box M77, Missenden Road Post Office, NSW, 2050 Australia.

Abstract

Background

Viruses are frequently associated with acute exacerbations of asthma, but the extent to which they contribute to the level of day-to-day symptom control is less clear.

Objective

We sought to explore the relationship between viral infections, host and environmental factors, and respiratory symptoms in children.

Methods

Sixty-seven asthmatic children collected samples twice weekly for an average of 10 weeks. These included nasal wash fluid and exhaled breath for PCR-based detection of viral RNA, lung function measurements, and records of medication use and asthma and respiratory symptoms in the previous 3 days. Atopy, mite allergen exposure, and vitamin D levels were also measured. Mixed-model regression analyses were performed.

Results

Human rhinoviruses (hRVs) were detected in 25.5% of 1232 nasal samples and 11.5% of breath samples. Non-hRV viruses were detected in less than 3% of samples. hRV in nasal samples was associated with asthma symptoms (cough and phlegm: odds ratio = 2.0; 95% CI = 1.4-2.86, P = .0001; wheeze and chest tightness: odds ratio = 2.34, 95% CI = 1.55-3.52, P < .0001) and with cold symptoms, as reported concurrently with sampling and 3 to 4 days later. No differences were found between the 3 hRV genotypes (hRV-A, hRV-B, and hRV-C) in symptom risk. A history of inhaled corticosteroid use, but not atopic status, mite allergen exposure, or vitamin D levels, modified the association between viruses and asthma symptoms.

Conclusion

The detection of nasal hRV was associated with a significantly increased risk of day-to-day asthma symptoms in children. Host, virus genotype, and environmental factors each had only a small or no effect on the relationship of viral infections to asthma symptoms.

Le texte complet de cet article est disponible en PDF.

Key words : Virus, rhinovirus, asthma, asthma control, children, mixed-model analysis, respiratory

Abbreviations used : c-ACT, CCQ, GAPDH, HDM, hRV, ICS, PEF, SPT


Plan


 Supported by the National Health and Medical Research Council of Australia (grant 633238).
 Disclosure of potential conflict of interest: E. R. Tovey has received research and salary support from the National Health and Medical Research Council (Australia) (Project 633238, Fellowship 571126). B. G. Oliver and G. B. Marks have received research support from the National Health and Medical Research Council (Australia), G.B.M.: Fellowship 1060614, Project 632857, 570919, 632781, 633238; B.G.O.: Fellowship 1026880, Project 1023131, 633238. H. K. Reddel is on the advisory board and DSMB for AstraZeneca; has served on advisory boards and DSMBs for Boehringer Ingelheim, GlaxoSmithKline, and Novartis; is on the DSMB for Merck; has had consultant arrangements with AstraZeneca, Biota, and Mundipharma; has received research support from AstraZeneca and GlaxoSmithKline; and has received payment for lectures from AstraZeneca, GlaxoSmithKline, and Novartis. A. Jaffe has previously served on medical advisory committees for Singulair (MSD), Xolair (Novartis), and Bronchitol (Pharmaxis). The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 3

P. 663 - mars 2015 Retour au numéro
Article précédent Article précédent
  • Neighborhood poverty, urban residence, race/ethnicity, and asthma: Rethinking the inner-city asthma epidemic
  • Corinne A. Keet, Meredith C. McCormack, Craig E. Pollack, Roger D. Peng, Emily McGowan, Elizabeth C. Matsui
| Article suivant Article suivant
  • Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma
  • Jantina C. de Groot, Eric N.H. van Roon, Huib Storm, Nic J.G.M. Veeger, Aeilko H. Zwinderman, Pieter S. Hiemstra, Elisabeth H.D. Bel, Anneke ten Brinke

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.